The introduction to the issue notes the emergence of gastroenterology as a “major hub” for obesity management, according to a June 5 news release from the American College of Gastroenterology.
Obesity and weight loss management tools, including medications such as Ozempic, are becoming more commonly discussed across every field of medicine.
Topics discussed in the issue include the use of GLP-1s in preparation for colonoscopy, food insecurity and its relationship to fatty liver disease and small bowel microbiomes and obesity.
In addition, more gastroenterology practices, including West Long Branch, N.J.-based Allied Digestive Health, are investing in weight loss care.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.